Big Take: 23andMe Bankruptcy Puts a Price on Your DNA
The genetic testing company 23andMe filed for bankruptcy in March, after years of slowing sales, legal trouble, and a declining stock price. And now, the valuable trove of genetic data the company owns is for sale, sparking privacy concerns. On today's Big Take, Bloomberg biotech reporter Gerry Smith traces the rise and fall of 23andMe, and bankruptcy reporter Jonathan Randles outlines what a possible sale could mean for millions of users' genetic data.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
an hour ago
- Bloomberg
US Economy Has Been 'Relying on Kindness of Strangers' For 3 Years
Jayati Bharadwaj, FX and macro strategist at TD Securities, breaks down why the US Dollar has remained weak, even as other economic indicators are strong amid Trump's trade war. (Source: Bloomberg)
Bloomberg
an hour ago
- Bloomberg
NRG CEO Coben Expects Data Center Deals All Over US
Bloomberg Markets: The Close NRG Energy President and CEO Larry Coben says there's not enough electricity in the grid to power nuclear energy. Speaking on "Bloomberg The Close," Coben also discusses the company's LS Power deal and energy regulation. (Source: Bloomberg)
Bloomberg
an hour ago
- Bloomberg
Big Take: Everything We Know About the Air India Crash
Moments after taking off, an Air India flight bound for London from an airport in Western India crashed with over 200 passengers on board. Hundreds have died and a search for survivors is ongoing. On today's Big Take podcast, Bloomberg's Benedikt Kammel joins host Sarah Holder to discuss what the crash of Boeing's marquee 787 Dreamliner means for the company and the commercial aviation industry at large.
